4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000187
Chairperson & CEO sold 9,500 shares at an average $593.99 ($5,642,870)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-11 | Sale : show line 2 in the form 10b5-1 | −25 | $584.20 | $14,605 | 333,918 | I |
| 2026-11-11 | Sale : show line 3 in the form 10b5-1 | −215 | $585.93 | $125,976 | 333,703 | I |
| 2026-11-11 | Sale : show line 4 in the form 10b5-1 | −320 | $586.59 | $187,709 | 333,383 | I |
| 2026-11-11 | Sale : show line 5 in the form 10b5-1 | −271 | $588.16 | $159,391 | 333,112 | I |
| 2026-11-11 | Sale : show line 6 in the form 10b5-1 | −292 | $589.18 | $172,040 | 332,820 | I |
| 2026-11-11 | Sale : show line 7 in the form 10b5-1 | −301 | $590.31 | $177,684 | 332,519 | I |
| 2026-11-11 | Sale : show line 8 in the form 10b5-1 | −736 | $591.56 | $435,389 | 331,783 | I |
| Open-market sales · 9,500 sh · avg $593.99 · $5,642,870 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-11 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −9,500 | 43,410 | I |
Loading xslF345X06/primarydocument.xml…